In-situ polymerization on the biological valve enables a hydrogel to form for pre-mounted artificial heart valves. The pre-mounted dry-tissue transcatheter valve developed by Wang’s group ...

NYHA: New York Heart Association. In an effort to improve the outcomes of patients with stented biological valves, stentless valves were introduced to clinical practices in the early 1990s.

Mechanical valves last longer, but blood can clot on them. A patient may need long-term medication that prevents blood clots developing. Biological valves are more likely to wear out.

Heart valve replacement is a life-saving treatment, but it is rarely a long-term solution. Both mechanical and biological valves have their own drawbacks. Patients with mechanical valves must take ...

and using a bypass machine to maintain blood circulation while the old valve is replaced with a new mechanical or biological valve. Recovery and Outcomes: The recovery period for the SAVR ...

This pioneering innovation envisions the development of biological heart valves that can grow and be accommodated naturally within the human body. This opens the door to a new era in heart disease ...